Hefei Lifeon Pharmaceutical Co., Ltd. announced that at its Annual General Meeting held on 09 May 2022, approved cash dividend/10 shares (tax included) of CNY 7.00000000 for the year 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.99 CNY | -0.99% |
|
+3.04% | -14.78% |
05-21 | Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution | MT |
05-15 | Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.78% | 528M | |
+41.25% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.55% | 246B | |
0.00% | 225B | |
+10.51% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 003020 Stock
- News Hefei Lifeon Pharmaceutical Co., Ltd.
- Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021